Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.51 |
| ▸ | RAD51 | Q06609 | 2/20 | 0.48 |
| ▸ | CYP11B2 | P19099 | 9/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 9/20 | 0.46 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4741913 | 0.80 | GPBAR1 (0.68) | GPBAR1RAD51CYP11B2CYP11B1CYP17A1 | |
| SCHEMBL4743145 | 0.67 | GPBAR1 (0.66) | GPBAR1RAD51CYP11B2CYP11B1CYP17A1 | |
| SCHEMBL4741378 | 0.67 | GPBAR1 (1.00) | GPBAR1 | |
| SCHEMBL4879950 | 0.67 | GPBAR1 (0.83) | GPBAR1CYP11B2CYP11B1CYP19A1CYP2C9 | |
| SCHEMBL4741853 | 0.67 | GPBAR1 (0.83) | GPBAR1CYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL4742051 | 0.67 | GPBAR1 (0.66) | GPBAR1RAD51CYP11B2CYP11B1CYP19A1 | |
| SCHEMBL10690882 | 0.66 | ALDH1A1 (0.63) | RAD51CYP2C9NPC1RAB9AMAPT | |
| SCHEMBL20816328 | 0.66 | RAD51 (1.00) | RAD51CYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL10689435 | 0.65 | RAD51 (0.61) | RAD51CYP2C9NPC1RAB9AMAPT | |
| SCHEMBL29469449 | 0.65 | KMT2A (0.53) | ALDH1A1PDK1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080221161-A1 | HETEROCYCLIC MODULATORS OF TGR5 FOR TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2008-09-11 | — | — | US | disclosed |
| WO-2008097976-A1 | HETEROCYCLIC MODULATORS OF TGR5 FOR TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2008-08-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221161-A1 | HETEROCYCLIC MODULATORS OF TGR5 FOR TREATMENT OF DISEASE | GPR119, GPBAR1, LDLR | GPBAR1 2/4885RAD51 4838/4885CYP11B2 1261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.